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Abstract Vitamin E (tocopherols and tocotrienols) is essential
for normal neurological function. Recently we have reported
that the neuroprotective properties of tocotrienols are much
more potent than that of the widely studied tocopherols (Sen,
C.K., Khanna, S., Roy, S. and Parker, L. (2000) J. Biol. Chem.
275, 13049^13055). The objective of this study was to evaluate
whether (i) oral supplementation of tocotrienols during preg-
nancy is bioavailable to fetal and mother brains; (ii) short-
term change in dietary vitamin E levels of pregnant rats in£u-
ences gene expression pro¢le of developing fetal brains. We
report that dietary tocotrienol is bioavailable to both mother
and fetal brains. The enrichment is more in fetal brain tissue.
Using a GeneChip microarray expression pro¢ling approach we
have identi¢ed a speci¢c set of vitamin E sensitive genes in the
developing rat fetal brain.
9 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Vitamin E is essential for normal neurological function
[1,2]. Based on symptoms of primary vitamin E de¢ciency,
it has been demonstrated that vitamin E has a central role
in maintaining neurological structure and function [2]. Most
of the vitamin E sensitive neurological disorders are associ-
ated with elevated levels of oxidative damage markers. This
has led to the popular hypothesis stating that the neuropro-
tective e¡ects of vitamin E are mediated by its antioxidant
property [3]. Vitamin E is a generic term for all tocopherols
and their derivatives having the biological activity of RRR-K-
tocopherol [4,5]. In nature, eight substances have been found
to have vitamin E activity: K-, L-, Q- and N-tocopherol; and
K-, L-, Q- and N-tocotrienol. Often, the term vitamin E is syn-
onymously used with K-tocopherol. While D-K-tocopherol
(RRR-K-tocopherol) has the highest bioavailability and rep-
resents the standard against which all the others must be com-
pared, it is only one out of eight natural forms of vitamin E.
Tocotrienols, formerly known as j-, O- or R-tocopherols, are
chemically similar to tocopherols except that they have an
isoprenoid tail with three unsaturation points instead of a
saturated phytyl tail. While tocopherols are predominantly
found in corn, soybean and olive oils, tocotrienols are partic-
ularly rich in palm, rice bran and barley oils [4,5]. Tocotri-
enols have been long known to possess powerful antioxidant,
anti-cancer and cholesterol-lowering properties. Tocotrienols
are thought to have more potent antioxidant properties than
K-tocopherol [6,7]. The unsaturated side chain of tocotrienol
allows for more e⁄cient penetration into tissues that have
saturated fatty layers such as the brain and liver [8]. Superior
antioxidant, free radical scavenging e¡ects of tocotrienol com-
pared to that of tocopherol appear to be due to their better
distribution in the fatty layers of the cell membrane [8]. While
tocotrienols have shown better bene¢cial e¡ects than K-to-
copherol in a limited number of situations indicated above,
little is known about the exact mechanism of action. Micro-
molar amounts of tocotrienols, but not tocopherols, have
been shown to suppress the activity of hydroxy-3-methylglu-
taryl coenzyme A reductase, the hepatic enzyme responsible
for cholesterol synthesis [9,10]. We have observed that K-to-
cotrienol is much more potent than K-tocopherol in inhibiting
glutamate-induced signal transduction pathways leading to
neurodegeneration [11]. Previously it has been suggested that
dietary K-tocotrienol does not reach the brain [12]. The ob-
jective of this study was two-fold. First, to con¢rm whether
tocopherol and tocotrienol fed to pregnant rats reach the
mother and fetal brains using a HPLC-CoulArray technique
recently developed in our laboratory [13]. Second, we utilized
a high-density oligonucleotide microarray approach to screen
the developing (day 17 of gestation) fetal brain transcriptome
for vitamin E sensitive genes.
2. Materials and methods
2.1. Animals and supplementation protocol
Pregnant (3 days) rats (10 weeks old; Sprague^Dawley, Harlan,
Indianapolis, IN, USA) were randomly divided into following two
groups: (i) Eþ group ^ fed a standard rat chow that is enriched in
K-tocopherol (V200 nmol/g diet). Additionally, this group was sup-
plemented for 2 weeks with a daily gavage of tocotrienol rich fraction
(TRF) suspended in vitamin E-stripped corn oil (Harlan). A mixture
of 110 mg K-tocopherol and 119 mg of K-tocotrienol contained in 1 g
TRF was fed to pregnant rats on a per kg body-weight basis. TRF
was provided in the form of Tocomin0 50% provided by Carotech
Sdn Bhd (Perak, Malaysia); (ii) E3 group ^ fed a vitamin E de¢cient
diet (TD88163, Harlan; K-tocopherol/tocotrienol levels below detec-
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tion limits) and supplemented with a matched volume of vitamin
E-stripped corn oil. All rats were maintained under standard condi-
tions at 22N 2‡C with 12:12 h dark:light cycles. All animal protocols
were approved by the Institutional Laboratory Animal Care and Use
Committee (ILACUC) of the Ohio State University, Columbus, OH,
USA. Sample collection. On 17th day of gestation, body weights of
each rat were recorded. Rats were killed. Mother and fetal brains were
removed, rinsed in ice-cold phosphate-bu¡ered saline, pH 7.4 (PBS)
and snap frozen in liquid nitrogen. Samples were brie£y stored in
380‡C.
2.2. Vitamin E extraction and analysis
Vitamin E extraction and analysis from mother and fetal brains was
performed as described previously using a HPLC-coulometric elec-
trode array detector (Coularray Detector ^ model 5600 with 12 chan-
nels; ESA Inc., Chelmsford, MA, USA) [13]. This system uses multi-
ple channels with di¡erent redox-potentials. K-, Q- and N-tocopherols
and tocotrienols were detected on channels set at 200 mV, 300 mV,
and 400 mV, respectively.
2.3. A¡ymetrix GeneChip probe array analysis
Total RNA was extracted by pulverizing the fetal brains in liquid
N2 followed by extraction using Trizol (Gibco BRL) [14,15]. A further
clean up of RNA was performed using the RNeasy kit (Qiagen).
Targets were prepared for microarray hybridization according to pre-
viously described protocols [14]. To assess sample quality the samples
were hybridized for 16 h at 45‡C to GeneChip Test-2 arrays. Satis-
factory samples were hybridized to Rat Genome arrays (U34A). The
arrays were washed, stained with streptavidin^phycoerythrin and were
then scanned with the GeneArray scanner (Agilent Technologies) in
our own facilities.
Raw data were collected and analyzed using A¡ymetrix Microarray
Suite 4.0 (MAS) and Data Mining Tool 2.0 (DMT) software. The
following two approaches were utilized to identify di¡erentially ex-
pressed genes: (i) using comparison analysis in MAS, six pair-wise
comparisons were generated from replicates of both Eþ and E3
groups. Average fold-changes were calculated for both up- or down-
regulated genes. Genes for which the concordance exceeded 50% in
pair-wise comparisons were selected, especially if the gene was de-
tected with redundant probe sets; (ii) T-test was performed using
DMT, and genes that signi¢cantly (P6 0.05) changed (increased or
decreased) in the Eþ group compared to the E3 group were selected.
The average di¡erence values of selected genes were loaded into the
Cluster and TreeView software [16]. The data was adjusted according
to the median center for a clear graphic display of vitamin E sensitive
genes.
2.4. Reverse-transcription and polymerase chain reaction (RT-PCR)
Expression levels of hemeoxygenase 3 (HO-3), cyclin D1, high-mo-
bility group protein 2 (HMG2), nucleolar phosphoprotein p130
(NOPP140) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA were independently determined using RT-PCR as
described previously [17]. In brief, the total RNA (1 Wg) was tran-
scribed into cDNA using oligo-dT primer and Superscript II. RT-
generated cDNA were ampli¢ed by PCR using gene-speci¢c primers
as described in Table 1. PCR reaction products were electrophoresed
in a 1% agarose gel containing 0.25 Wg/ml ethidium bromide. The gel
was digitally imaged under conditions of ultraviolet transillumination.
Quanti¢cation of band intensity was performed using the Scion Image
(Scion Corporation) that is based on NIH Image software.
3. Results
3.1. Vitamin E levels in mother and fetal brains
K-Tocopherol level in the fetal brain was multi-fold lower
than that observed in the mother brain (Fig. 1A). Compared
to Eþ group, feeding a vitamin E de¢cient diet for only
2 weeks during pregnancy did not signi¢cantly decrease the
K-tocopherol levels in the adult mother brain. However, under
similar conditions, feti from the mothers of E3 group had
signi¢cantly lower K-tocopherol levels in brain compared to
the feti from Eþ group (Fig. 1A). K-Tocotrienol was below
detection limits in the brains of mothers as well as feti of the
E3 group. Oral supplementation of TRF for 2 weeks to moth-
ers during pregnancy resulted in delivery of K-tocotrienol to
the mother as well as fetal brains. Importantly, incorporation
of tocotrienol in the fetal brain was signi¢cantly higher com-
pared to that in the mother brain (Fig. 1B). Of interest, short-
term vitamin E de¢ciency in pregnancy diet did not in£uence
vital parameters of pups such as weight or general health (our
unpublished observations).
3.2. Transcriptome pro¢ling
The transcriptomes of developing fetal brains from Eþ and
E3 groups were compared using the U34A rat genome high-
density oligonucleotide GeneChip array. This array analyzes
approximately 7000 full-length sequences and approximately
1000 EST clusters. Using raw data from all replicates avail-
able from both groups, a total of six pair-wise comparisons
were generated. The average (six pair-wise comparisons) fold-
changes of all the genes that were di¡erentially expressed were
calculated. Data indicated that a majority of genes remained
unchanged (Fig. 2). A total of 645 (7.3%) genes were up-regu-
lated in vitamin Eþ group compared to the E3 group. Out of
which 416 genes increased by a magnitude of two-fold or
Table 1
Primers used for RT-PCR
mRNA Primer sequence 5P to 3P
Cyclin D1 CTG CAT GTT CGT GGC CTC TAA GAT
CCA GAA GGG CTT CAA TCT GTT CCT
GAPDH TAT GAC TCT ACC CAC GGC AAG TTC A
CAG TGG ATG CAG GGA TGA TGT TCT
HMG2 TCC TCC CAA AGG TGA TAA GAA AGG A
TGG CAC GGT ATG CAG CAA TA
HO-3 ATG GCA TCA GAG AAG GAA AAC CAT T
CCC ATC AAG TAT TGA GAG CCC ATT C
NOPP140 TCA GTG CCA CCA AGA GTC CCT TAA
CTT CTT CAC TGG AAT CTT CGG AGG A
Fig. 1. Vitamin E levels in fetal and mother rat brains. Pregnant
(3 days) rats were randomly divided into (i) Eþ group ^ fed a stan-
dard rat chow that is enriched in K-tocopherol. Additionally, this
group was supplemented for 2 weeks with a daily gavage of TRF
suspended in vitamin E-stripped corn oil; and (ii) E3 group ^ fed a
vitamin E de¢cient diet and supplemented with a matched volume
of vitamin E-stripped corn oil. On the 17th day of gestation, brains
were collected and vitamin E analysis was performed using HPLC.
*P6 0.05 signi¢cantly di¡erent compared to the Eþ group. #P6 0.05
signi¢cantly di¡erent compared to mother brain. n.d., not detected.
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more. On the other hand 152 (1.7%) of the genes were down-
regulated with 74 of them lowered by two-fold or more (Fig.
2). Using the t-test analysis (see Section 2 for details), a total
144 genes were observed to have changed signi¢cantly
(P6 0.05) in vitamin E de¢ciency group compared to the
supplemented group. The data was adjusted according to
the median center for a clear graphic display of vitamin E
sensitive genes (Fig. 3A,B). Next, genes for those the concor-
dance exceeded 50% in pair-wise comparisons were selected,
especially if the gene was detected with redundant probe sets.
Using this approach of data analysis, a total of 19 probe sets
were found to be up-regulated and 34 repressed in Eþ group
compared to E3 group (Tables 2 and 3). Among the up-regu-
lated genes, two probe sets targeting HO-3 were increased by
3.9 and 3.1 folds, respectively (Fig. 4). In contrast, the expres-
sion of maspin, GAPDH, apolipoprotein B (apoB) and G
protein beta1 subunit (rGb1) genes was highly (three- to
¢ve-fold) repressed in response to dietary vitamin E.
3.3. Validation of GeneChip data using RT-PCR
Select vitamin E sensitive genes identi¢ed by the GeneChip
approach were veri¢ed using conventional semi-quantitative
RT-PCR (Fig. 4). The band intensity of the PCR products
was quanti¢ed and fold change for each gene in Eþ group
compared to E3 group was calculated. Data showed that
fold change detected using both GeneChip or RT-PCR ap-
proaches for genes up-regulated Eþ vs. E3 groups were com-
parable (Fig. 4). For GAPDH, both microarray as well as
RT-PCR data indicated a decrease in expression in Eþ group
compared to E3 group. However, the fold-change in GAPDH
expression was much higher in the microarray data compared
to the RT-PCR data (Fig. 4).
4. Discussion
We present ¢rst evidence showing that consumption of a
vitamin E de¢cient diet for only 2 weeks during pregnancy
can substantially lower the vitamin E levels of fetal brain
while not a¡ecting the vitamin E levels of adult brain under-
scoring the importance of proper levels of this vitamin in the
diet during pregnancy. Compared to an adult brain, a higher
uptake of the K-tocotrienol form of vitamin E by fetal brain
was also observed. Results of this study provide the ¢rst glob-
al assessment of vitamin E sensitive genes in a developing fetal
brain. Of the 8000 genes surveyed, only 17 genes displayed an
increase in gene expression levels in fetal brain as a result of
vitamin E feeding to mothers, whereas 34 displayed a decrease
Fig. 2. Range of the average fold changes of di¡erentially expressed
genes in Eþ and E3 groups. Six pair-wise comparisons were gener-
ated from replicates of both Eþ and E3 groups using comparison
analysis in MAS. Average fold changes were calculated for both up-
or down-regulated genes in response to dietary vitamin E. NC=no
charge.
Table 2
Genes up-regulated in fetal brains of Eþ group
A¡ymetrix accession number Description
M13100cds#1_at HO-3 or RATLIN3A
X05472cds#2_at RNREP24R, rat 2.4 kb repeat DNA right terminal region
X07686cds_s_at rat L1Rn B6 repetitive DNA element
M13100cds#1_g_at HO-3 or LINE3 (L1Rn)
rc_AA800912_g_at GTF2I repeat domain-containing 1 putative ortholog
rc_AA924591_at Cyp4a locus, encoding cytochrome P450 (IVA3)
X62951mRNA_s_at mRNA (pBUS19) with repetitive elements
rc_AI231445_at unr protein
rc_AA852046_s_at VL30 element mRNA
AB010154_at PKN mRNA for serin/threonine protein kinase expressed in hippocampus
rc_AI231257_at cyclin D1
X53581cds#3_f_at long interspersed repetitive DNA containing seven ORFs
AF055714UTR#1_at hypertension-regulated vascular factor-1C-4
X05472cds#3_f_at RNREP24R rat 2.4 kb repeat DNA right terminal region
S76466_at type I serine-threonine kinase receptor
S78556_at 75 kDa glucose-regulated protein
rc_AA998882_s_at NOPP140
D84418_r_at chromosomal protein HMG2
U35244_g_at vacuolar protein sorting homolog r-vps33a
Six pair-wise comparisons among brains obtained from individual feti, the mothers of whom were fed vitamin Eþ and vitamin E3 diet during
pregnancy for 2 weeks. Genes for those the concordance exceeded 50% in pair-wise comparisons were selected, especially if the gene was de-
tected with redundant probe sets. ESTs for which no description is available were excluded.
FEBS 26518 10-10-02 Cyaan Magenta Geel Zwart
S. Roy et al./FEBS Letters 530 (2002) 17^23 19
in expression indicating that a highly speci¢c set of genes are
sensitive to the vitamin E levels in a developing fetal brain.
Based on symptoms of primary vitamin E de¢ciency in
adults, it has been demonstrated that vitamin E has a central
role in maintaining neurological structure and function [2].
However, e¡orts to systematically evaluate the molecular ba-
sis of vitamin E action on the brain are lacking. Our data
show that K-tocopherol level in the fetal brain was multi-
fold lower than that observed in the mother brain. This
data is in accordance with a previous study where K-tocoph-
erol levels in fetal brain were lower compared to that of the
brains of 21-day-old rats [18]. Furthermore, in humans, the
serum K-tocopherol levels in full-term neonates are known to
be several folds lower (0.212N 0.127 vs. 1.160N 0.513 mg/dl)
Fig. 3. Cluster image illustrating the genes di¡erentially expressed in fetal brains of Eþ group. For a clear graphic display of vitamin E sensitive
genes, t-test was performed on replicate samples of Eþ group (animals #7, #10, #11) and E3 group (animals # 12 and #13) that signi¢cantly
(P6 0.05) changed (increase or decrease) in the Eþ group as compared to the E3 group. The average di¡erence values of selected genes were
loaded into the Cluster and TreeView software where the data was adjusted according to the median center. Red to green gradation in color
represent higher to lower expression signal compared to median center. In some cases due to very high expression levels the signal is saturated
and shows red in all samples. The scale is digitally adjustable. A medium intensity (not optimal for all data presented) scale is shown. For de-
tails of vitamin E feeding and tissue collection, see legend of Fig. 1. A: Up-regulated; or (B) down-regulated genes in Eþ group compared to
E3 group.
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Fig. 3 (Continued).
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compared to that of their mothers [19]. We have previously
shown that compared to K-tocopherol, tocotrienols are strik-
ingly more potent in protecting neuronal cells against gluta-
mate-induced degeneration [11]. However, in vivo data dem-
onstrating the availability of dietary tocotrienols in the brain
was lacking. The present study provides ¢rst evidence that
dietary supplementation of TRF during pregnancy leads to
a signi¢cant enrichment of K-tocotrienol in both maternal
and fetal brains. Dietary vitamin E is absorbed in the intestine
and carried by lipoproteins to the liver. In the liver, the
K-tocopherol fraction is incorporated into very low-density
lipoprotein (VLDL) by a K-tocopherol transfer protein and
then secreted into the bloodstream [20]. A recent study shows
that scavenger receptor class B type I (SR-BI), which mediates
cellular selective cholesteryl ester uptake from lipoproteins,
facilitates e⁄cient transfer of K-tocopherol from high-density
lipoprotein (HDL) to cultured cells [21]. Furthermore, in SR-
BI-de¢cient mutant mice, relative to wild-type control ani-
mals, there was a signi¢cant increase in plasma K-tocopherol
levels (1.1- to 1.4-fold higher) that was mostly due to the
elevated K-tocopherol content of their abnormally large plas-
ma HDL-like particles [21]. Mechanisms of uptake and trans-
port of tocotrienols in organs and tissues are poorly under-
stood in adults and more so in fetal tissues.
HO-3 was one of the few vitamin E sensitive genes up-
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Fig. 4. RT-PCR validation of GeneChip microarray expression anal-
ysis. Expression levels of were independently determined using RT-
PCR. The following genes identi¢ed as di¡erentially expressed in Eþ
group compared to E3 group using GeneChip microarray analysis
were veri¢ed using RT-PCR: HO-3, cyclin D1, HMG2, NOPP140
and GAPDH. The band intensity of the PCR products was quanti-
¢ed and fold change for each gene in Eþ group compared to E3
group was calculated (solid bars). For comparison, fold changes ob-
served in the expression of a speci¢c gene using GeneChip microar-
ray analysis (one or more probe sets) was also plotted (empty and
hatched bars).
Table 3
Genes down-regulated in fetal brains of Eþ group
A¡ymetrix accession number Description
U58857_at maspin
AFFX_rat_GAPDH_M_st GAPDH
M27440_at apoB
U88324_g_at rGb1
AFFX_rat_beta-actin_3_st cytoplasmic beta-actin
rc_AI045858_at weakly similar to T14794 hypothetical protein DKFZp586P1522
rc_AI008852_at eukaryotic translation elongation factor
U46118_at cytochrome P450 3A9
L27112_s_at stress-activated protein kinase alpha II
rc_AA965261_at H2A histone family, member Y
AF091563_r_at QIL-LD1 olfactory receptor
AB013454_at NaPi-2 beta
M27467_at cytochrome oxidase subunit VIc
U50412_at phosphoinositide 3-kinase regulatory subunit p85alpha
U88324_at rGb1
M32474_at carcinoembryonic antigen-related protein
AF037071_at carboxyl-terminal PDZ ligand of neuronal NO synthase
AB010436_at cadherin-8
L03386_i_at zinc ¢nger protein
rc_AI072341_at vacuolar protein sorting homolog r-vps33b
rc_AI073204_at tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
rc_AI103498_at ribosomal protein L5
D16308_at cyclin D2
rc_H31847_at dynein light intermediate chain
D17521_at PKC-regulated chloride channel
D90038_at 70 kDa peroxisomal membrane protein
rc_AI171630_s_at p38 mitogen-activated protein kinase
AF083330_at kinesin-like protein KIF3C
M65251_s_at rat angiotensinogen gene-inducible enhancer-binding protein 1
rc_AA892378_at AF151893 1 CGI-135 protein
rc_AA800194_at similar to T08812 probable succinate-CoA ligase
AF090867_g_at guanosine monophosphate reductase mRNA
D14045_s_at DNA topoisomerase IIA
rc_AI179150_s_at CDK110
Six pair-wise comparisons among brains obtained from individual feti, the mothers of whom were fed vitamin Eþ and vitamin E3 diet during
pregnancy for 2 weeks. Genes for those the concordance exceeded 50% in pair-wise comparisons were selected, especially if the gene was de-
tected with redundant probe sets. ESTs for which no description is available were excluded.
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regulated in fetal brains. HO isozymes, HO-1, HO-2 and HO-
3, are heat shock protein 32 protein cognates with a known
function of catalyzing the isomer-speci¢c oxidation of the
heme molecule, including that of NO synthase [22]. HO-1 is
highly inducible, whereas HO-2 and HO-3 are constitutively
expressed. These proteins play a central role in the cellular
defense mechanisms. HO activity is responsible for the pro-
duction of equimolar amounts of CO, biliverdin and free Fe
[22,23]. Recent ¢ndings with the HOs suggest that these pro-
teins may serve as an intracellular ‘sink’ for NO [24]. LINE1
was identi¢ed to be another vitamin E sensitive transcript.
The LINE-1, or L1 family of interspersed repeats accounts
for at least 10% of the mammalian genome. Like other inter-
spersed repeat DNA families in genomes of other organisms,
L1 is dispersed and ampli¢ed throughout the genome by a
series of duplicative transposition events. Due to the high
copy number of L1 sequences in the genome, L1 is abun-
dantly represented in the RNA population of most cells.
However, most of the transcripts that contain L1 are the
result of fortuitous transcription and are not intermediates
in L1 retrotransposition. This high background of L1-contain-
ing transcripts, many of which are truncated and rearranged,
makes it di⁄cult to distinguish the transcript encoded by an
active L1 element(s) [25]. ApoB mRNA was one of top can-
didates that were lower in Eþ group compared to the E3 fetal
group. ApoB plays a central role in lipoprotein metabolism
and exists in two isoforms in plasma, apoB-100 and apoB-48
[26]. High levels of apoB and LDL cholesterol have been
associated with an increased risk for coronary heart disease
[27]. An earlier study has shown that administration of TRF
(100 mg/day) decreases serum apoB [28]. Tocopherol has been
shown to inhibit protein kinase C (PKC) activity in cells [29].
PKC-regulated chloride channel was one of the genes that
were suppressed in the Eþ group.
Taken together, these results provide evidence that com-
pared to the adult brain, fetal brain is de¢cient in vitamin E
and that fetal brain vitamin E status is tightly linked to the
dietary vitamin E intake of the mother. Dietary tocotrienol is
bioavailable to the brain. Gene expression patterns in re-
sponse to dietary vitamin E suggest that vitamin E in preg-
nancy diet favorably in£uences the gene expression pro¢le of
the developing fetal brain.
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